Prudential Financial’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,403
| Closed | -$25.9K | – | 2485 |
|
|
2025
Q1 | $25.9K | Hold |
2,403
| – | – | ﹤0.01% | 2239 |
|
|
2024
Q4 | $30.8K | Sell |
2,403
-4,845
| -67% | -$62K | ﹤0.01% | 2254 |
|
|
2024
Q3 | $200K | Hold |
7,248
| – | – | ﹤0.01% | 2516 |
|
|
2024
Q2 | $210K | Buy |
7,248
+2,450
| +51% | +$71K | ﹤0.01% | 2472 |
|
|
2024
Q1 | $214K | Buy |
4,798
+2,195
| +84% | +$97.9K | ﹤0.01% | 2453 |
|
|
2023
Q4 | $101K | Hold |
2,603
| – | – | ﹤0.01% | 2501 |
|
|
2023
Q3 | $76.5K | Hold |
2,603
| – | – | ﹤0.01% | 2466 |
|
|
2023
Q2 | $166K | Buy |
2,603
+1,980
| +318% | +$126K | ﹤0.01% | 2451 |
|
|
2023
Q1 | $29.4K | Sell |
623
-5
| -0.8% | -$236 | ﹤0.01% | 2545 |
|
|
2022
Q4 | $43.6K | Buy |
628
+4
| +0.6% | +$278 | ﹤0.01% | 2504 |
|
|
2022
Q3 | $92K | Buy |
624
+6
| +1% | +$885 | ﹤0.01% | 2518 |
|
|
2022
Q2 | $81K | Buy |
618
+70
| +13% | +$9.18K | ﹤0.01% | 2543 |
|
|
2022
Q1 | $55K | Buy |
+548
| New | +$55K | ﹤0.01% | 2569 |
|